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association for height and CRC risk was similar in men and 
women. The significant association for BMI and CRC risk 
was stronger in men than in women.
Conclusion The positive association between height and 
risk of CRC suggests that life factors during childhood and 
early adulthood might play a role in CRC aetiology. Higher 
general and abdominal body fatness during adulthood are 
risk factors of CRC and these associations are stronger in 
men than in women.
Keywords Height · BMI · Colorectal cancer · Meta-
analysis · Continuous update project
Introduction
Colorectal cancer (CRC) is the second most common cancer 
in women and the third most common cancer in men with 
614,000 new cases diagnosed among women and 746,000 
cases in men worldwide in 2012. It is a leading cause of 
cancer-related death, resulting in around 700,000 deaths 
worldwide [1].
In the World Cancer Research Fund (WCRF)/Ameri-
can Institute for Cancer Research report from 2011, it was 
stated that the evidence that greater adult attained height 
increases colorectal cancer risk was convincing, based on 
the results from eight studies [2]. Since then, ten additional 
large cohort studies have been published on height and colo-
rectal cancer [3–11]. In addition, Mendelian Randomization 
studies have suggested a causal association between height 
and colorectal cancer [12, 13], however, one of these found 
an association only among women [12]. No previous meta-
analyses have examined the shape of the dose–response 
relationship between height and colorectal cancer, and the 
most recent meta-analysis did not investigate whether the 
Abstract 
Purpose There is no published dose–response meta-anal-
ysis on the association between height and colorectal cancer 
risk (CRC) by sex and anatomical sub-site. We conducted 
a meta-analysis of prospective studies on the association 
between height and CRC risk with subgroup analysis and 
updated evidence on the association between body fatness 
and CRC risk.
Methods PubMed and several other databases were 
searched up to November 2016. A random effects model 
was used to calculate dose–response summary relative risks 
(RR’s).
Results 47 studies were included in the meta-analyses 
including 50,936 cases among 7,393,510 participants. The 
findings support the existing evidence regarding a positive 
association of height, general and abdominal body fatness 
and CRC risk. The summary RR were 1.04 [95% (CI)1.02–
1.05, I² = 91%] per 5 cm increase in height, 1.02 [95% 
(CI)1.01–1.02, I² = 0%] per 5 kg increase in weight, 1.06 
[95% (CI)1.04–1.07, I² = 83%] per 5 kg/m2 increase in BMI, 
1.02 [95% (CI)1.02–1.03, I² = 4%] per 10 cm increase in 
waist circumference, 1.03 [95% (CI)1.01–1.05, I² = 16%] 
per 0.1 unit increase in waist to hip ratio. The significant 
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association persisted in subgroup analyses stratified by study 
characteristics.
Adiposity is also an established risk factor for colorectal 
cancer, both as measured by body mass index (BMI) and 
waist circumference and waist-to-hip ratio. Although many 
studies have investigated the association between BMI and 
colorectal cancer [8, 9, 14–40], fewer studies have been pub-
lished on abdominal fat measures and colorectal cancer risk. 
Although the World Cancer Research Fund (WCRF)/Con-
tinuous Update Project (CUP) 2011 report [2] concluded that 
there was convincing evidence for an association between 
both general and abdominal fatness and colorectal cancer, 
the analyses for waist circumference and colorectal, colon 
and rectal cancer were based on only 3, 6 and 3 studies, 
respectively [24, 27, 41–46]. Previous meta-analyses [47, 
48] have not investigated the shape of the dose–response 
relationship between BMI, waist circumference or waist-to-
hip ratio and colorectal cancer [47, 48]. New studies, that 
could have been included in our meta-analysis, have been 
published on BMI (n = 24) [8, 9, 11, 14, 15, 17–24, 49–51], 
waist circumference (n = 13) [9, 16, 18, 22–24, 52, 53] and 
waist-to-hip ratio (n = 6) [9, 16, 18, 49, 53] and colorectal 
cancer since the WCRF/CUP 2011 report and for this rea-
son we conducted an updated meta-analysis of the avail-
able evidence from prospective studies. We aimed to clarify 
the strength and shape of the dose–response relationship 
between height, weight, BMI, waist circumference, and 
waist-to-hip ratio and colorectal cancer risk and to clarify 
any potential differences by sex, and geographical location.
Materials and methods
Search strategy
PubMed, Embase, CABAbstracts, ISI Web of Science, 
BIOSIS, LILACS, Cochrane library, CINAHL, AMED, 
National Research Register and In Process Medline were 
searched for studies on anthropometric measures includ-
ing BMI, height, weight, waist circumference and waist 
to hip ratio, and colorectal cancer risk up to December 
2015. The specific search criteria and the review proto-




The search was restricted to cohort (prospective, retrospec-
tive, case–cohort or nested case–control studies) studies 
which investigated the link between anthropometric meas-
ures and colorectal cancer risk and reported estimates of 
the relative risk (RR) (e.g., hazard ratio, risk ratio or odds 
ratio) and 95% confidence intervals (CIs) for the exposures 
of interest (BMI, height, weight, waist circumference, and 
waist-to-hip ratio), total number of cases and person years 
of follow-up. If there were multiple publications from the 
same study, the newest publication which included the larg-
est number of cases was selected.
Data extraction
From each publication, the following data were extracted: 
first author’s last name, year of publication, the study name, 
period of follow-up, sample size, age, sex, number of cases, 
country where the study was conducted, assessment method 
of exposure (self-reported vs measured), anthropometric 
measures, their quantities and their associated RRs and 95% 
CIs, and variables used in adjustment in the analysis. The 
update search and data extraction from January 2010 up to 
November 2016 was conducted by three authors (LA, AR, 
JGS) and was checked for accuracy by two authors (TN, 
LA).
Statistical methods
The associations between height, weight, BMI, waist cir-
cumference and waist-to-hip ratio and colorectal, colon and 
rectal cancer were investigated using random effect mod-
els to calculate the summary RRs and 95% CIs to take into 
account heterogeneity across studies [54]. Q and I² statis-
tics were used to determine heterogeneity [55] and were 
explored in stratified analyses. Low proportion of heteroge-
neity across studies was defined by an I2 < 30%, moderate 
proportion by an I2 = 30–50%, and high proportion by an 
I2 ≥ 50%.
Continuous risk estimates were used directly when avail-
able in the articles, and for studies that only reported cat-
egorical data dose–response associations and 95% CIs were 
derived using generalized least-squares for trend estimation 
[56], which required the RRs and CIs associated to at least 
three categories of anthropometric measures, and number 
of cases and non-cases or person years of follow-up per cat-
egory to be available. If only the total number of cases or 
person years was reported in the articles, and the exposure 
was categorised in quantiles, the distribution of cases or 
person years was calculated by dividing the total number of 
cases or person years by the number of quantiles.
The mean or median values per category were used if 
provided in the articles, or the midpoint was calculated for 
studies that only reported a range by category. If the range 
of the highest or lowest category was open-ended, its width 
was assumed to be the same as the adjacent category. If the 
results were reported for men and women separately, they 
were combined using a fixed effects meta-analysis before 
being pooled with other studies.
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Small-study effects, such as publication bias, were 
assessed using funnel plots and Egger’s test [57].
A potential nonlinear dose–response association 
between anthropometric measures and colorectal cancer 
risk was assessed by calculating restricted cubic splines 
for each study with more than three categories of expo-
sure, using three fixed knots at 10, 50, and 90% through 
the total distribution of the reported measurements, and 
combined them using multivariate meta-analysis. Indica-
tion of non-linearity was tested using likelihood ratio test.
For all analyses, the results of each paper with the 
most comprehensive adjustment for confounders were 
included. A two-tailed p < 0.05 was considered statisti-
cally significant.
Fig. 1  Flowchart of study selection
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Stata version 12 software (StataCorp, College Station, 
TX, USA) was used.
Results
In total, 47 studies including 50,960 cases among 7,393,510 
participants were included in the meta-analysis of anthropo-
metric measures and colorectal, colon (proximal and distal), 
and rectal cancer risk (flowchart of study selection—Fig. 1). 




Fourteen studies (84,095 cases) were included in the 
dose–response meta-analysis [3, 5, 6, 8, 9, 11, 26, 30, 
58–63]. The summary RR for an increase of 5 cm was 1.04 
(95% CI 1.02–1.05) (Fig. 2a). There was high heterogene-
ity (I² = 91%, Pheterogeneity < 0.001) and evidence of pub-
lication or small-study bias (P value Egger’s test < 0.05).
In stratified analysis the associations were similar in 
men and women and were stronger in studies in North 
America compared to studies in Europe. In addition, the 
associations tended to be stronger in studies in which 
height was measured than self-reported and in studies with 
less than 10 years of follow-up (Table 1).
No evidence of nonlinear association was observed 
(Pnonlinearity = 0.33, n = 10) (Fig. 2b).
Height and colon cancer
Fourteen studies (92,069 cases) were included in the 
dose–response meta-analysis [4, 5, 7, 26, 30, 33, 41, 45, 
58, 64–67]. The summary RR for an increase of 5 cm was 
1.02 (95% CI 1.02–1.03). There was high heterogeneity 
(I² = 87%, Pheterogeneity < 0.001) (Table 1, Supplemental 
Fig. 1A). There was evidence of publication or small study 
bias (P value Egger’s test < 0.001).
In stratified analysis by sex and geographical location, 
the summary RR showed similar association in studies 
in men and women and stronger association in studies 
in North America than studies in Europe. No significant 
association was observed in studies in Asia including two 
studies (Table 1).
There was evidence of a significant non-linear asso-
ciation (Pnonlinearity = 0.03, n = 9), showing a significant 
Fig. 2  Height and colorectal cancer risk (dose–response and nonlinear analysis). RR relative risk, 95% CI 95% confidence interval. Summary 
RR calculated using a random-effects model
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Table 1  Summary of results
Height, per 5 cm
n RR (95% CI) I2 (%) Ph
Colorectal cancer
All studies 14 1.04 (1.02–1.05) 91 < 0.001
Stratified by sex
 Men 8 1.04 (1.03–1.05) 0 0.46
 Women 10 1.04 (1.02–1.05) 91.5 < 0.001
Stratified by geographic location
 Europe 6 1.03 (1.00–1.07) 95.6 < 0.001
 North America 7 1.06 (1.01–1.11) 79.7 < 0.001
 Asia 1 1.03 (0.95–1.10) – –
 Australia – – – –
Duration of follow-up
 < 10 years follow-up 4 1.06 (1.04–1.08) 0 0.75
 10–< 15 years follow-up 5 1.05 (1.00–1.11) 83.9 < 0.001
 ≥ 15 years follow-up 5 1.03 (1.00–1.07) 94.3 < 0.001
Assessment of height
 Measured 6 1.05 (1.04–1.06) 0 0.47
 Self-reported 8 1.01 (1.00–1.02) 68.8 0.002
Number of cases
 Cases < 1000 7 1.05 (1.00–1.09) 0 0.58
 Cases 1000–3000 4 1.04 (1.00–1.09) 87 < 0.001
 Cases ≥ 3000 3 1.04 (1.00–1.08) 98 < 0.001
Colon cancer
All studies 14 1.02 (1.02–1.03) 87 < 0.001
Stratified by sex
 Men 9 1.02 (1.01–1.04) 75.3 < 0.001
 Women 12 1.02 (1.01–1.03) 85.7 < 0.001
Stratified by geographic location
 Europe 5 1.01 (1.00–1.02) 86 < 0.001
 North America 6 1.05 (1.01–1.10) 89.7 < 0.001
 Asia 2 1.12 (0.96–1.32) 79.2 0.03
 Australia 1 1.13 (1.04–1.23) – –
Proximal colon cancer
All studies 4 1.02 (0.99–1.05) 76.1 < 0.01
Stratified by sex
 Men 2 1.12 (0.90–1.40) 78.6 0.03
 Women 4 1.01 (0.99–1.03) 52.3 0.09
Stratified by geographic location
 Europe 1 1.03 (0.96–1.11) 0 0.60
 North America 2 1.01 (1.00–1.01) 0 0.82
 Asia – – – –
 Australia 1 1.24 (1.11–1.39) 0 0.74
Distal colon cancer
All studies 4 1.01 (1.00–1.01) 0 0.85
Stratified by sex
 Men 2 1.05 (0.92–1.19) 45.5 0.17
 Women 4 1.01 (1.00–1.02) 16.9 0.31
Stratified by geographic location
 Europe 1 1.05 (0.94–1.17)
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Table 1  (continued)
Height, per 5 cm
n RR (95% CI) I2 (%) Ph
 North America 2 1.01 (1.00–1.01) 0 0.58
 Asia – – – –
 Australia 1 1.04 (0.87–1.24)
Rectal cancer
All studies 14 1.01 (1.00–1.02) 61.7 0.002
Stratified by sex
 Men 10 1.02 (1.00–1.05) 39.7 0.09
 Women 12 1.01 (1.00–1.01) 57.8 0.006
Stratified by geographic location
 Europe 6 1.00 (1.00–1.01) 37.0 0.16
 North America 5 1.06 (1.02–1.10) 28.5 0.24
 Asia 2 1.04 (1.00–1.09) 0 0.61
 Australia – – – –
Weight, per 5 kg
n RR (95% CI) I2 (%) Ph
Colorectal cancer
All studies 4 1.02 (1.01–1.02) 0 0.58
Stratified by sex
 Men 2 1.01 (1.00–1.02) 0 0.59
 Women 1 1.02 (1.01–1.03) – –
Stratified by geographic location
 Europe 3 1.02 (1.01–1.03) – –
 North America 1 1.02 (1.01–1.03) – –
 Asia – – – –
 Australia – – – –
Duration of follow-up
 < 10 years follow-up 1 1.02 (1.00–1.03) – –
 10–< 15 years follow-up 1 1.01 (1.00–1.03) – −
 ≥ 15 years follow-up 2 1.02 (1.01–1.03) 5.7 0.30
Assessment of weight
 Measured 2 1.02 (0.99–1.05) 35.5 0.21
 Self-reported 2 1.02 (1.01–1.03) 0 0.88
Number of cases
 Cases < 1000 3 1.02 (1.01–1.03) 0 0.43
 Cases 1000–3000 – – – –
 Cases ≥ 3000 – – – –
Colon cancer
All studies 6 1.02 (1.01–1.03) 18 0.29
Stratified by sex
 Men 4 1.02 (1.01–1.02) 0 0.68
 Women 2 1.05 (1.01–1.09) 6 0.30
Stratified by geographic location
 Europe 3 1.01 (1.00–1.02) 0 0.92
 North America 1 1.03 (1.01–1.05) – –
 Asia – – – –
 Australia 2 1.05 (1.01–1.09) 6 0.30
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Table 1  (continued)
Weight, per 5 kg
n RR (95% CI) I2 (%) Ph
Proximal colon cancer
All studies 3 1.02 (1.00–1.04) 34 0.22
Stratified by sex
 Men 1 1.01 (0.98–1.04)
 Women 2 1.03 (0.98–1.09) 66.3 0.08
Stratified by geographic location
 Europe 1 1.01 (0.98–1.04)
 North America 1 1.01 (1.00–1.03)
 Asia – – – –
 Australia 1 1.07 (1.01–1.14)
Distal colon cancer
All studies 3 1.03 (1.01–1.05) 23 0.27
Stratified by sex
 Men 1 1.02 (0.99–1.05)
 Women 2 1.05 (0.99–1.11)
Stratified by geographic location
 Europe 1 1.02 (0.99–1.05)
 North America 1 1.02 (1.01–1.04)
 Asia – – – –
 Australia 1 1.09 (1.01–1.18)
Rectal cancer
All studies 4 1.01 (1.00–1.02) 0 0.65
Stratified by sex
 Men 3 1.01 (1.00–1.02) 0 0.78
 Women 1 1.06 (0.71–1.57) – –
Stratified by geographic location
 Europe 3 1.01 (1.00–1.02) 0 0.78
 North America 1 1.04 (0.99–1.10) – –
 Asia – – – –
 Australia – – – –
BMI, per 5 kg/m²
n RR (95% CI) I2 (%) Ph1
Colorectal cancer
All studies 38 1.06 (1.04–1.07) 83 < 0.001
Stratified by sex
 Men 20 1.08 (1.05–1.12) 83 < 0.001
 Women 24 1.05 (1.03–1.07) 83.7 < 0.001
Stratified by geographic location
 Europe 10 1.04 (1.02–1.06) 80.8 < 0.001
 North America 13 1.05 (1.03–1.07) 61.2 0.003
 Asia 15 1.09 (1.01–1.18) 86.2 < 0.001
 Australia – – – –
Duration of follow-up
 < 10 years follow-up 13 1.05 (1.03–1.07) 33.7 0.11
 10–< 15 years follow-up 19 1.06 (1.03–1.09) 91.7 < 0.001
 ≥ 15 years follow-up 6 1.05 (1.02–1.07) 23.7 0.26
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Table 1  (continued)
BMI, per 5 kg/m²
n RR (95% CI) I2 (%) Ph1
Assessment of weight/height
 Measured 25 1.05 (1.03–1.07) 28.1 0.17
 Self-reported 13 1.06 (1.04–1.08) 85.9 < 0.001
Number of cases
 Cases < 1000 22 1.03 (1.02–1.05) 15.7 0.25
 Cases 1000–3000 4 1.06 (1.03–1.09) 59.2 0.06
 Cases ≥ 3000 11 1.09 (1.04–1.15) 97.6 < 0.001
Colon cancer
All studies 42 1.07 (1.05–1.08) 78.8 < 0.001
Stratified by sex
 Men 26 1.10 (1.07–1.13) 74.2 < 0.001
 Women 30 1.04 (1.02–1.05) 57 < 0.01
Stratified by geographic location
 Europe 13 1.05 (1.03–1.07) 80.6 < 0.001
 North America 14 1.08 (1.05–1.11) 75.8 < 0.001
 Asia 14 1.09 (1.03–1.16) 78.6 < 0.001
 Australia 1 1.13 (1.00–1.28) – –
Proximal colon cancer
All studies 20 1.05 (1.03–1.08) 44.0 0.04
Stratified by sex
 Men 12 1.13 (1.05–1.21) 33.2 0.20
 Women 16 1.04 (1.01–1.07) 30.4 0.17
Stratified by geographic location
 Europe 1 1.12 (0.99–1.27)
 North America 11 1.04 (1.02–1.07) 33.1 0.13
 Asia 8 1.16(1.06–1.27)
 Australia – – – –
Distal colon cancer 51.6 0.01
All studies 20 1.08 (1.04–1.11)
Stratified by sex
 Men 12 1.23 (1.08–1.38) 77 < 0.01
 Women 16 1.05 (1.03–1.08) 0 0.60
Stratified by geographic location
 Europe 1 1.34 (1.16–1.53)
 North America 11 1.05 (1.03–1.08) 0 0.53
 Asia 8 1.18 (1.17–1.29)
 Australia – – – –
Rectal Cancer
All studies 36 1.02 (1.01–1.03) 29.3 0.07
Stratified by sex
 Men 24 1.02 (1.01–1.04) 21.8 0.20
 Women 25 1.01 (0.99–1.03) 43.6 0.02
Stratified by geographic location
 Europe 15 1.01 (1.00–1.02) 32.1 0.13
 North America 11 1.02 (0.99–1.05) 23.9 0.24
 Asia 14 1.04 (1.02–1.06) 0 0.71
 Australia 1 1.02 (0.97–1.08) – –
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Table 1  (continued)
Waist circumference, per 10 cm
n RR (95% CI) I2 (%) Ph1
Colorectal cancer
All studies 10 1.02 (1.02–1.03) 4.2 0.40
Stratified by sex
 Men 5 1.03 (0.99–1.06) 77.9 0.001
 Women 6 1.03 (1.02–1.04) 0 0.90
Stratified by geographic location
 Europe 2 1.01 (0.99–1.04) 34.4 0.22
 North America 5 1.03 (1.01–1.04) 30.7 0.23
 Asia 3 1.03 (1.01–1.05) 0 0.79
 Australia – –
Duration of follow-up
 < 10 years follow-up 5 1.02 (1.01–1.04) 0 0.97
 10–<15 years follow-up 2 1.00 (0.98–1.03) 0 0.65
 ≥ 15 years follow-up 3 1.06 (0.98–1.14) 69.5 0.07
Assessment of waist circumference
 Measured 4 1.02 (1.00–1.05) 0 0.76
 Self-reported 6 1.02 (1.01–1.04) 40.7 0.15
Number of cases
 Cases < 1000 9 1.02 (1.01–1.03) 12.9 0.33
 Cases 1000–3000 1 1.03 (1.01–1.04) – –
 Cases ≥ 3000 – –
Colon cancer
All studies 11 1.05 (1.02–1.07) 72 < 0.001
Stratified by sex
 Men 7 1.09 (1.03–1.15) 95 < 0.001
 Women 8 1.03 (1.01–1.04) 0.7 0.42
Stratified by geographic location
 Europe 2 1.02 (1.01–1.04) 0 0.88
 North America 6 1.04 (1.01–1.08) 69.9 0.01
 Asia 2 1.05 (1.02–1.08) – –
 Australia – – – –
Proximal colon cancer
All studies 5 1.05 (1.01–1.09) 49.9 0.09
Stratified by sex
 Men 2 1.12 (0.95–1.31) 79 0.03
 Women 2 1.03 (1.01–1.05) 0 0.50
Stratified by geographic location
 Europe 1 1.04 (0.98–1.10)
 North America 4 1.06 (1.01–1.11) 62.1 0.05
 Asia – – – –
 Australia – – – –
Distal colon cancer
All studies 5 1.06 (1.02–1.11) 50.5 0.09
Stratified by sex
 Men 2 1.14 (0.94–1.38) 83.5 0.01
 Women 2 1.14 (1.01–1.06) 0 0.65
Stratified by geographic location
 Europe 1 1.05 (0.98–1.11)
 Eur J Nutr
1 3
Table 1  (continued)
Waist circumference, per 10 cm
n RR (95% CI) I2 (%) Ph1
 North America 4 1.07 (1.01–1.14) 62.8 0.04
 Asia – – – –
 Australia – – – –
Rectal cancer
All studies 8 1.03 (1.00–1.05) 45.7 0.10
Stratified by sex
 Men 6 1.02 (0.98–1.06) 59.2 0.03
 Women 5 1.04 (1.01–1.06) 0 0.48
Stratified by geographic location
 Europe 2 1.02 (1.00–1.05) 0 0.59
 North America 2 1.07 (0.95–1.09) 82.7 0.02
 Asia 1 1.00 (0.97–1.04) – –
 Australia 1 1.12 (0.99–1.27) – –
Waist-to-hip ratio, per 0.1 unit
n RR (95% CI) I2 (%) Ph
Colorectal cancer
All studies 6 1.03 (1.01–1.05) 15.7 0.31
Stratified by sex
 Men 2 1.18 (0.88–1.60) 81.8 0.02
 Women 4 1.03 (1.01–1.04) 0 0.72
Stratified by geographic location
 Europe – – – –
 North America 4 1.04 (1.00–1.08) 0 0.99
 Asia 2 1.02 (0.98–1.06) 68 0.08
 Australia – – – –
Duration of follow-up
 < 10 years follow-up 1 1.04 (1.00–1.08) – –
 10–<15 years follow-up 1 1.02 (0.97–1.07) – –
 ≥ 15 years follow-up 4 1.06 (0.98–1.14) 52.5 0.12
Assessment of waist-to-hip ratio
 Measured 2 1.08 (0.95–1.22) 76.2 0.04
 Self-reported 2 1.02 (0.99–1.04) 36.7 0.21
Number of cases
 Cases < 1000 5 1.04 (1.00–1.08) 30.5 0.23
 Cases 1000–3000 1 1.03 (1.01–1.04) – –
 Cases ≥ 3000 – – – –
Colon cancer
All studies 7 1.16 (1.05–1.28) 82.5 < 0.001
Stratified by sex
 Men 4 1.17 (1.05–1.30) 88.2 < 0.001
 Women 5 1.07 (1.00–1.15) 60.8 0.04
Stratified by geographic location
 Europe 1 1.27 (1.13–1.43) – –
 North America 3 1.14 (0.98–1.32) 78.5 0.01
 Asia 2 1.05 (1.00–1.10) 0 0.46
 Australia 1 1.47 (1.27–1.71) – –
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increased risk with increasing height (Supplemental 
Fig. 1B).
Height and proximal and distal colon cancer
Four studies were included in the dose–response meta-
analysis of height and proximal (1326 cases) and distal 
(1275 cases) colon cancer.
The summary RR for proximal colon cancer per an 
increase of 5 cm was 1.02 (95% CI 0.99–1.05) (Table 1 
and Supplemental Fig.  2A). High heterogeneity was 
observed (I² = 76%, Pheterogeneity < 0.01). There was no 
evidence of publication bias (P value Egger’s test = 0.96).
In stratified analysis by sex, no significant associa-
tion was observed. In stratified analysis by geographical 
location, a borderline significant increased risk was 
observed in studies conducted in North America.
There was no evidence of a non-linear association 
(Pnonlinearity = 0.41, n = 3) (Supplemental Fig. 2B).
The summary RR for distal colon cancer per an increase 
of 5 cm was 1.01 (95% CI 1.00–1.01) (Table 1; Supple-
mental Fig. 3A). No heterogeneity was observed (I² = 0%, 
Pheterogeneity = 0.85). There was a significant evidence of 
publication bias (P value Egger’s test = 0.04).
In stratified analysis by sex and geographical location, 
positive associations were borderline significant in stud-
ies in women and not in men, and in studies conducted in 
North America.
There was an evidence of a significant non-linear asso-
ciation (Pnonlinearity = 0.01, n = 3) (Supplemental Fig. 3B).
Table 1  (continued)
Waist-to-hip ratio, per 0.1 unit
n RR (95% CI) I2 (%) Ph
Proximal colon cancer
All studies 4 1.13 (1.00–1.28) 72.5 < 0.01
Stratified by sex
 Men 2 1.41 (1.17–1.72) 0 0.68
 Women 3 1.03 (0.96–1.11) 43.2 0.17
Stratified by geographic location
 Europe – – – –
 North America 3 1.06 (0.95–1.09) 71.9 0.03
 Asia – – – –
 Australia 1 1.36 (1.10–1.38) 0 0.49
Distal colon cancer
All studies 4 1.17 (1.01–1.35) 74.6 < 0.01
Stratified by sex
 Men 2 1.50 (0.91–2.47) 82.9 0.01
 Women 3 1.04 (1.02–1.06) 0 0.73
Stratified by geographic location
 Europe – – – –
 North America 3 1.04 (1.02–1.06) 0 0.58
 Asia – – – –
 Australia 1 1.52 (0.92–1.50) 78.5 0.03
Rectal cancer
All studies 6 1.04 (1.01–1.08) 22.1 0.26
Stratified by sex
 Men 4 1.05 (1.02–1.09) 0 0.62
 Women 4 1.06 (0.98–1.15) 44.9 0.14
Stratified by geographic location
 Europe 1 1.04 (0.98–1.09) – –
 North America 2 1.03 (0.98–1.09) 0 0.63
 Asia 2 1.12 (0.98–1.28) 0 0.96
 Australia 1 1.24 (1.02–1.51) – –
RR relative risk; 95% CI 95% confidence interval
 Eur J Nutr
1 3
Height and rectal cancer
Fourteen studies (30,762 cases) were included in the 
dose–response meta-analysis [4, 5, 8, 11, 26, 30, 33, 41, 45, 
58, 64–66]. The summary RR for an increase of 5 cm was 
1.01 (95% CI 1.00–1.02) (Table 1; Supplemental Fig. 4A). 
There was high heterogeneity (I² = 62%, Pheterogeneity = 
0.002). There was evidence of a significant publication or 
small study bias (P value Egger’s test < 0.001).
In stratified analysis, the summary RR showed a slightly 
stronger association in studies in men than in women and 
a stronger association in studies in North America than in 
studies in Asia and Europe (Table 1).
There was no evidence of a non-linear association 
(Pnonlinearity = 0.08, n = 9) (Supplemental Fig. 4B).
Weight
Weight and colorectal cancer
Four studies (2700 cases) were included in the meta-analysis 
[9, 26, 27, 39]. The summary RR per an increase of 5 kg 
was 1.02 (95% CI 1.01–1.02) (Fig. 3a) and there was no 
evidence.
of heterogeneity (I² = 0%, Pheterogeneity = 0.58). There was 
no evidence of a publication or small study bias (P value 
Egger’s test = 0.49).
In stratified analysis by sex and geographical location, 
positive significant associations were almost similar in both 
men and women and in studies conducted in Europe and 
North America.
There was no significant evidence of a non-linear associa-
tion (Pnonlinearity = 0.43, n = 3) (Fig. 3b).
Weight and colon cancer
Six studies (2143 cases) were included in the meta-analysis 
[26, 27, 45, 68–70]. The summary RR per an increase of 
5 kg was 1.02 (95% CI 1.01–1.03) (Table 1; Supplemen-
tal Fig. 5A). No heterogeneity was observed (I² = 18%, 
Pheterogeneity = 0.29). There was evidence of a significant 
publication or small study bias (P value Egger’s test = 0.01).
In stratified analysis, the summary RR showed stronger 
associations in studies in women than in men and in studies 
conducted in Australia than in Europe (Table 1).
There was no significant evidence of a non-linear asso-
ciation (Pnonlinearity = 0.84, n = 3) (Supplemental Fig. 5B).
Weight and proximal and distal colon cancer
Three studies were included in dose–response meta-analy-
sis for proximal (1748 cases) and distal (1083 cases) colon 
cancer.
The summary RR for proximal colon cancer per an 
increase of 5 kg was 1.02 (95% CI 1.00–1.04) (Table 1; 
Supplemental Fig. 6A). No heterogeneity was observed (I² 
= 34%, Pheterogeneity = 0.22). There was no evidence of pub-
lication bias (P value Egger’s test = 0.73).
Fig. 3  Weight and colorectal cancer risk (dose–response and nonlinear analysis). RR relative risk, 95% CI 95% confidence interval. Summary 
RR calculated using a random-effects model
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In stratified analysis by sex, no significant association was 
observed.
There was no significant evidence of a non-linear asso-
ciation (Pnonlinearity = 0.31, n = 2) (Supplemental Fig. 6B).
The summary RR for distal colon cancer per an increase 
of 5 cm was 1.03 (95% CI 1.01–1.05) (Table 1; Supple-
mental Fig. 7A). No heterogeneity was observed (I² = 23%, 
Pheterogeneity = 0.27). There was no evidence of publication 
bias (P value Egger’s test = 0.76).
In stratified analysis by sex, no significant association was 
observed.
There was no significant evidence of a non-linear asso-
ciation (Pnonlinearity = 0.48, n = 2) (Supplemental Fig. 7B).
Weight and rectal cancer
Four studies (1186 cases) were included in the meta-anal-
ysis [26, 27, 41, 45]. The summary RR per an increase of 
5 kg was 1.01 (95% CI 1.00–1.02) (Table 1; Supplemen-
tal Fig.  8A). No heterogeneity was observed (I² = 0%, 
Pheterogeneity = 0.65) (Table 1).
In stratified analysis by geographical location, positive 
significant association was observed in studies in Europe.
There was no significant evidence of a non-linear asso-
ciation (Pnonlinearity = 0.29, n = 3) (Supplemental Fig. 8B).
Body mass index (BMI)
BMI and colorectal cancer
Thirty-eight studies (84 859 cases) were included in the 
dose–response meta-analysis [8, 9, 11, 14, 15, 18–24, 26–32, 
34–40, 50, 51]. The summary RR for an increase of 5 kg/m2 
was 1.06 (95% CI 1.04–1.07) (Fig. 4a). There was evidence 
of high heterogeneity (I² = 83%, Pheterogeneity < 0.001). There 
was evidence of a publication or small study bias (P value 
Egger’s test < 0.001).
Several differences in associations emerged in stratified 
analyses by study size, years of follow-up and in studies in 
which weight and height were self-assessed and in those 
in which they were measured, but none of them were sta-
tistically significant (Table 1). The associations tended to 
be stronger in men than in women and when the analysis 
was restricted to studies that reported in both sex, the sum-
mary RR were 1.05 (95% CI 1.03–1.07) in women and 1.08 
(95% CI 1.05–1.12) in men. The association was stronger 
in studies in Asia than in studies conducted in Europe and 
North America. The associations tended to be stronger in 
studies in which weight and height were self-reported com-
pared to measured, in studies with higher number of cases 
(> 3000), and in studies with 10–< 15 years of follow-up. 
However, none of these variables independently explained 
the heterogeneity.
Fig. 4  BMI and colorectal cancer risk (dose–response and nonlinear analysis). RR relative risk, 95% CI 95% confidence interval. Summary RR 
calculated using a random-effects model
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There was statistical evidence of a non-linear relationship 
(Pnonlinearity < 0.001, n = 29) (Fig. 4b). Colorectal cancer risk 
increased with increasing BMI and the risk appeared to be 
stronger from a BMI increases around 27 kg/m2 and above.
BMI and colon cancer
Forty two studies (85,295 cases) were included in the 
dose–response meta-analysis [11, 14, 18–21, 24, 26–28, 30, 
31, 33, 35–37, 44, 45, 49, 66, 69–83]. The summary RR 
for an increase of 5 kg/m2 was 1.07 (95% CI 1.05–1.08) 
(Table 1; Supplemental Fig. 9A). There was high hetero-
geneity (I² = 79%, Pheterogeneity < 0.001). There was evi-
dence of publication or small study bias (P value Egger’s 
test < 0.001).
In analysis stratified by sex and geographical location, the 
summary RR showed stronger associations in studies in men 
than women and stronger associations in studies in Asia and 
North America than studies in Europe (Table 1).
There was no statistical evidence of a non-linear associa-
tion (Pnonlinearity = 0.09, n = 33) (Supplemental Fig. 9B).
BMI and proximal and distal colon cancer
Twenty studies were included in dose–response meta-analy-
sis for proximal (8437 cases) and distal (14,985 cases) colon 
cancer. There was evidence of significant positive association 
between BMI and both proximal and distal colon cancer risk, 
that was slightly stronger for distal than for proximal cancer.
The summary RR for proximal colon cancer per an 
increase of 5 kg/m2 was 1.05 (95% CI 1.03–1.08) (Table 1; 
Supplemental Fig.  10A). Medium heterogeneity was 
observed (I² = 44%, Pheterogeneity = 0.04). There was no evi-
dence of publication bias (P value Egger’s test = 0.06).
In stratified analysis by sex and geographical location, 
positive significant associations were stronger in men than 
in women and in studies conducted in Asia than in North 
America.
There was no statistical evidence of a non-linear asso-
ciation (Pnonlinearity = 0.14, n = 8) (Supplemental Fig. 10B).
The summary RR for distal colon cancer for an increase 
of 5 kg/m2 was 1.08 (95% CI 1.04–1.11) (Table 1; Sup-
plemental Fig. 11A). High heterogeneity was observed (I² 
= 52%, Pheterogeneity = 0.02). There was no evidence of 
publication bias (P value Egger’s test = 0.08).
In stratified analysis by sex and geographical location, 
positive significant associations were stronger in men than 
in women and in studies conducted in Asia than in Europe 
and North America.
There was no statistical evidence of a non-linear asso-
ciation (Pnonlinearity = 0.49, n = 8) (Supplemental Fig. 11B).
BMI and rectal cancer
Thirty-six studies (73,186 cases) were included in the 
dose–response meta-analysis [8, 11, 14, 17–21, 24, 26–28, 
30, 31, 33, 35, 36, 41, 45, 49, 66, 70–72, 75, 76, 79, 80]. 
The summary RR for an increase of 5 kg/m2 was 1.02 
(95% CI 1.01–1.03) (Table 1; Supplemental Fig. 12A). 
There was no evidence of heterogeneity (I² = 29.3%, 
Pheterogeneity = 0.07). No evidence of publication or small 
study bias was detected (P value Egger’s test = 0.08).
Fig. 5  Waist circumference and colorectal cancer risk (dose–response analysis). RR relative risk, 95% CI 95% confidence interval. Summary RR 
calculated using a random-effects model
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In stratified analysis, the summary RR was statistically 
significant in men but not in women, and in studies in Asia 
and not in other geographic locations (Table 1).
There was evidence of a non-linear association 
(Pnonlinearity<0.001, n = 28) (Supplemental Fig. 12B). The 
curve shows that there is no evidence of association for 
BMI < 27.5  kg/m2, but increased risk for BMI values 
above this level.
Waist circumference
Waist circumference and colorectal cancer
Ten studies (1 884 cases) were included in the dose–response 
meta-analysis [9, 16, 18, 22–24, 27, 53]. The summary 
RR for an increase of 10 cm was 1.02 (95% CI 1.02–1.03) 
(Fig. 5a). There was no evidence of heterogeneity (I² = 4%, 
Pheterogeneity = 0.40) (Fig. 4a). There was no evidence of pub-
lication bias (P value Egger’s test = 0.60).
In stratified analysis, the positive associations were sig-
nificant only in women and not in men, in studies conducted 
in Asia and North America and not in studies in Europe, and 
in studies with less years of follow-up (< 10 years). In stud-
ies with measured or self-reported waist circumferences, the 
positive association was similar (Table 1).
There was no evidence of non-linear association 
(Pnonlinearity = 0.17, n = 7) (Fig. 5b).
Waist circumference and colon cancer
Eleven studies (4729 cases) were included in the 
dose–response meta-analysis [16, 18, 24, 27, 42–45, 53, 68]. 
The summary RR for an increase of 10 cm was 1.05 (95% 
CI 1.02–1.07) (Table 1; Supplemental Fig. 13A). High het-
erogeneity was observed (I² = 72%, Pheterogeneity = < 0.001). 
There was evidence of publication bias (P value Egger’s 
test < 0.01).
In stratified analysis by sex and geographic location, the 
positive significant associations were stronger in men than in 
women and in studies in Asia and North America compared 
to the studies conducted in Europe (Table 1).
There was a significant evidence of non-linear association 
(Pnonlinearity = 0.001, n = 8). The curve shows increased risk 
of colon cancer with increasing waist circumference, with 
steeper associations at lower levels compared to higher lev-
els of waist circumference (Supplemental Fig. 13B).
Waist circumference and proximal and distal colon cancer
Five studies were included in dose–response meta-analysis 
for proximal (1982 cases) and distal (1320 cases) colon 
cancer.
There were significant positive associations of similar 
magnitude between waist circumference and both proximal 
and distal colon cancer.
The summary RR for proximal colon cancer for an 
increase of 10 cm was 1.05 (95% CI 1.01–1.09). No het-
erogeneity was observed (I² = 49.9%, Pheterogeneity = 0.09) 
(Table 1; Supplemental Fig. 14A). There was no evidence 
of publication bias (P value Egger’s test = 0.41).
In stratified analysis by sex and geographical location, 
positive significant associations were observed in studies in 
women and not in men, and in studies conducted in North 
America.
There was no statistical evidence of a non-linear associa-
tion (Pnonlinearity = 0.41, n = 3) (Supplemental Fig. 14B).
The summary RR for distal colon cancer per an increase 
of 10 cm was 1.06 (95% CI 1.02–1.11). No heterogeneity 
was observed (I² = 50.5%, Pheterogeneity = 0.09) (Table 1; Sup-
plemental Fig. 15A). There was no evidence of publication 
bias (P value Egger’s test = 0.17).
In stratified analysis by sex and geographical location, 
positive significant associations were observed in studies in 
women and not in men, and in studies conducted in North 
America.
There was no statistical evidence of a non-linear associa-
tion (Pnonlinearity = 0.84, n = 3) (Supplemental Fig. 15B).
Waist circumference and rectal cancer
Eight studies (1980 cases) were included in the 
dose–response meta-analysis of waist circumference and 
rectal cancer [18, 24, 27, 41, 45, 53]. The summary RR for 
an increase of 10 cm was 1.03 (95% CI 1.00–1.05) (Table 1; 
Supplemental Fig. 16A). No heterogeneity was observed (I² 
Fig. 6  Waist-to-hip ratio and colorectal cancer risk (dose–response 
and nonlinear analysis). RR relative risk, 95% CI 95% confidence 
interval. Summary RR calculated using a random-effects model
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= 46%, Pheterogeneity = 0.10). There was no evidence of pub-
lication bias (P value Egger’s test = 0.30).
In stratified analysis by sex, significant association was 
observed only in women and not in men. In stratified analy-
sis by geographic location, the positive association was bor-
derline significant in studies in Europe and not significant in 
studies conducted in North America (Table 1).
There was no evidence of non-linear association 
(Pnonlinearity = 0.40, n = 6) (Supplemental Fig. 16B).
Waist‑to‑hip ratio
Waist‑to‑hip ratio and colorectal cancer
Six studies (4 689 cases) were included in the dose–response 
meta-analysis of waist to hip ratio and colorectal cancer [9, 
16, 18, 49, 53]. The summary RR for an increase of 0.1 unit 
was 1.03 (95% CI 1.01–1.05) (Fig. 6).
No heterogeneity was observed (I² =16%, Pheterogeneity 
=0.31). There was no evidence of publication bias (P value 
Egger’s test = 0.436).
In stratified analysis, positive significant associations 
were observed only in studies in women and not in men, 
and in studies in North America and not in studies conducted 
in Asia (Table 1).
There was no statistical evidence of a non-linear associa-
tion (Pnonlinearity = 0.34, n = 4) (Supplemental Fig. 6B).
Waist‑to‑hip ratio and colon cancer
Seven studies (3126 cases) were included in the 
dose–response meta-analysis of waist to hip ratio and colon 
cancer [18, 42, 43, 45, 49, 53, 68, 84]. The summary RR 
for an increase of 0.1 unit was 1.16 (95% CI 1.05–1.28) 
(Table 1; Supplemental Fig. 17A).
High heterogeneity was observed (I ²  =82%, 
Pheterogeneity < 0.001). There was no evidence of publication 
bias (P value Egger’s test = 0.14).
In stratified analysis by sex and geographic location, 
stronger association was observed in men compared to 
women and in studies in Europe than in studies in Asia 
(Table 1).
There was a significant evidence of non-linear associa-
tion, showing colon cancer risk increased with increasing 
waist-to-hip-ratio (Pnonlinearity = 0.001, n = 7) and the curve 
was approximately linear across the range of waist-to-hip 
ratio values (Supplemental Fig. 17B).
Waist‑to‑hip ratio and proximal and distal colon cancer
Four studies were included in dose–response meta-analy-
sis for proximal (1073 cases) and distal (932 cases) colon 
cancer. The summary RR for proximal colon cancer for an 
increase of 0.1 unit was 1.13 (1.00–1.28). High heterogene-
ity was observed (I² = 72.5%, Pheterogeneity <0.01) (Table 1; 
Supplemental Fig. 18). There was no evidence of publication 
bias (P value Egger’s test = 0.62).
In stratified analysis by sex, the positive association was 
only significant in men and not in women.
There was not enough studies to conduct non-linear anal-
ysis (n = 1).
The summary RR for distal colon cancer for an increase 
of 0.1 unit was 1.17 (95% CI 1.01–1.35). High heterogeneity 
was observed (I² = 74.6%, Pheterogeneity <0.01) (Table 1 and 
Supplemental Fig. 19). There was no evidence of publication 
bias (P value Egger’s test = 0.28).
In stratified analysis by sex and geographical location, the 
positive associations were significant only in women and not 
in men, and in studies in North America.
There was not enough studies to conduct non-linear anal-
ysis (n = 1).
Waist‑to‑hip ratio and rectal cancer
Six studies (1510cases) were included in the dose–response 
meta-analysis of waist to hip ratio and rectal cancer risk 
[18, 41, 45, 49, 53]. The summary RR for an increase of 
0.1 unit was 1.04 (95% CI 1.01–1.08) (Table 1; Supplemen-
tal Fig. 20A). No heterogeneity was observed (I² =22%, 
Pheterogeneity =0.26). There was no evidence of publication 
bias (P value Egger’s test = 0.42).
In stratified analysis by sex, positive association was only 
significant in men and not in women. In stratified analysis by 
location, no significant association was observed (Table 1).
There was no statistical evidence of a non-linear associa-
tion (Pnonlinearity = 0.14, n = 3) (Supplemental Fig. 20B).
Discussion
In this meta-analysis of prospective studies, we quantified 
the evidence for the association between adult height, gen-
eral obesity and abdominal fatness with CRC risk. To our 
knowledge this is the first dose–response meta-analysis to 
investigate the association between adult height and CRC 
risk. We found evidence of an increased risk of colorectal 
cancer with greater adult height. The association shows a 
4% increased risk per an increment of 5 cm of height for 
colorectal, 2 and 1% increased risk for colon cancer and 
rectal cancer, respectively. The trend of increasing risk with 
greater adult height was similar in men and women, which is 
in contradiction with the results of several previous observa-
tional studies, showing stronger association among women 
than in men [8, 9, 12, 26, 30, 45, 65, 67, 68]. Also stronger 
association was observed in studies in which height was 
measured rather than self-reported. Moreover, there was an 
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evidence of a non-linear association for greater adult height 
and colon cancer risk, with steeper associations at lower 
compared to higher levels of height.
The specific mechanism explaining the association 
between greater height and colorectal cancer risk has not 
been elucidated, although there is a great deal of evidences 
for an association between greater height and increased risk 
of other cancers including breast, pancreas, endometrium 
and ovarian cancers [85, 86]. Taller people have a greater 
number of cells in their body [87] and it has also been sug-
gested that height is associated with the length of the intes-
tines [88]; therefore, taller people might have a higher risk 
of cell mutations leading to malignancy. Elevated levels of 
insulin-like growth factor-1 (IGF-1) may play an important 
role in determining growth as higher IGF-1 levels in child-
hood are associated with childhood growth [34]. Elevated 
levels of IGF-1 may contribute to cancer risk by inhibiting 
apoptosis, stimulating cell proliferation and synthesis of 
sex steroids and inhibiting the synthesis of steroid hormone 
binding globulin [85, 89]. Nutritional status and diseases 
particularly infections during childhood and adolescence are 
play an important role in determining adult height [85, 90, 
91] as poor nutrition and infections are the main reasons of 
growth failures in early childhood [92, 93]. Furthermore, 
it has been suggested that adult height represents the bal-
ance between nutritional intake and losses over time, spe-
cifically during the growth periods, including losses due to 
physical activity, psychological stress, and disease from the 
conception to maturity [92] and consequently adult height 
is a product of cumulative net nutrition [92]. Cancer risk in 
adulthood might be related to early life conditions but why 
these conditions might differentially affect men and women 
is unknown.
Our findings also show a positive relationship between 
all the included anthropometric factors (weight, BMI, waist 
circumference and waist to hip ratio) and the risk of colo-
rectal cancer, and all the anatomical localizations (colon, 
proximal colon, distal colon, and rectal). Almost all positive 
associations were statistically significant.
The strongest association for BMI was observed with dis-
tal colon cancer, showing 8% increased risk for an increase 
of 5 kg/m² of BMI. The trend of increasing colorectal cancer 
risk with greater BMI was stronger in men than in women.
For waist circumference and waist to hip ratio, the 
strongest associations were observed with colon cancer, 
showing 5 and 16% increased risk per an increase of 10 cm 
of waist circumference and 0.1 increment of waist to hip 
ratio, respectively. Our results for an association between 
BMI and waist circumference and colorectal cancer risk 
are in agreement with the findings of two previous meta-
analyses [47, 48].
We observed a nonlinear association between BMI and 
colorectal cancer risk. Colorectal cancer risk increased with 
BMI which appears to be stronger from BMI above 27 kg/
m2 approximately. There was also evidence of non-linear 
association (P = 0.02) for BMI and colon cancer risk but 
the curve appeared approximately linear across the range of 
BMI values investigated. Furthermore, nonlinear associa-
tions were observed for abdominal fatness measures (waist 
circumference and waist to hip ratio) and colon cancer risk, 
with steeper associations at lower levels compared to higher 
levels of waist circumference. Several mechanisms are 
hypothesized to link obesity to colorectal cancer. Metabolic 
syndrome, elevated levels of insulin and insulin-like growth 
factors which inhibits apoptosis and modulates cell prolifera-
tion are suggested to play a role in the aetiology of colorec-
tal cancer [48, 94–96]. There are evidences suggesting that 
abdominal fatness measured by high waist circumference 
and waist to hip ratio is a better indicator of metabolic distur-
bances, that affect the risk of colorectal cancer, than general 
obesity measured by high BMI as BMI has the limitation 
of not distinguishing between fat mass and lean mass [53].
This study has several advantages. It is based on large-
scale prospective studies which minimize the probability of 
recall or selection bias, and also includes a large number of 
studies with relatively long follow-up and large number of 
cases that significantly increase the statistical power of the 
analysis. Moreover, the majority of the included studies in 
our meta-analysis were adjusted at least for age and other 
potential confounders such as alcohol consumption, smoking 
and physical activity.
However, the current meta-analysis has some limita-
tions which should be taken into account when interpreting 
the results. High heterogeneity was observed across stud-
ies, which would affect the reliability of the summary RR 
estimates and lead to less accurate results. We did not find 
an explanation for this heterogeneity as it persisted in most 
subgroup analyses. This high heterogeneity might be due to 
variations and differences in anthropometric measurements 
categories. Another limitation of this meta-analysis can 
be due to measurement errors in the assessment of anthro-
pometric measures, although most of the studies reported 
measured BMI (n = 27) rather than self-reported (n = 16).
In conclusion, our findings support the existing evidence 
of a positive association of general and abdominal body 
fatness with risk of CRC. In addition, higher adult height 
is significantly associated with increased colorectal cancer 
risk, particularly in women. These findings suggest that early 
life nutrition might play a role in colorectal cancer risk in 
adulthood.
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